Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Mallinckrodt
Medtronic
Moodys
McKesson

Last Updated: August 15, 2022

Cephalexin - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for cephalexin and what is the scope of freedom to operate?

Cephalexin is the generic ingredient in five branded drugs marketed by Alkem Labs Ltd, Apothecon, Aurobindo Pharma Ltd, Barr, Belcher Pharms, Chartwell Rx, Facta Farma, Hikma, Ivax Sub Teva Pharms, Lupin, Orchid Hlthcare, Purepac Pharm, Stevens J, Sun Pharm Inds (in), Sun Pharm Inds Ltd, Teva, Yoshitomi, Pragma, Hikma Pharms, Vitarine, Yung Shin Pharm, Ranbaxy Labs Ltd, and Lilly, and is included in fifty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-nine drug master file entries for cephalexin. Thirty-two suppliers are listed for this compound.

Drug Prices for cephalexin

See drug prices for cephalexin

Drug Sales Revenue Trends for cephalexin

See drug sales revenues for cephalexin

Recent Clinical Trials for cephalexin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Baylor Research InstitutePhase 4
Albert Einstein Healthcare NetworkPhase 4
The Plastic Surgery FoundationPhase 2

See all cephalexin clinical trials

Pharmacology for cephalexin
Medical Subject Heading (MeSH) Categories for cephalexin

US Patents and Regulatory Information for cephalexin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Facta Farma CEPHALEXIN cephalexin FOR SUSPENSION;ORAL 062117-002 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Pragma KEFLEX cephalexin FOR SUSPENSION;ORAL 050406-003 Approved Prior to Jan 1, 1982 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Barr CEPHALEXIN cephalexin TABLET;ORAL 062826-001 Aug 17, 1987 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Sun Pharm Inds (in) CEPHALEXIN cephalexin CAPSULE;ORAL 062791-001 Jun 11, 1987 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Barr CEPHALEXIN cephalexin TABLET;ORAL 062827-001 Aug 17, 1987 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Lilly KEFTAB cephalexin hydrochloride TABLET;ORAL 050614-001 Oct 29, 1987 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Colorcon
Johnson and Johnson
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.